Clinical investigation of medicinal products in the treatment of Parkinson's disease

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Reference numberCHMP/330418/2012 Rev. 2
Effective from02/07/2012
KeywordsParkinson’s disease, Parkinson, confirmatory trials
DescriptionThis document provides guidance on the development for medicinal products for the treatment of Parkinson's disease. Read together with questions and answers.

Document history

Revision 2 

Current version

Adopted guideline


In operation: 02/07/2012–present


Revision 1

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/02/2009–01/07/2012


Published: 30/07/2008


Published: 19/07/2007


Published: 17/11/2005

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more